What VIROPHARMA INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Milano Vincent | President and CEO | Jan 24 | Disposition to Issuer · D | −311,798 | — | — | 0 |
| Milano Vincent | President and CEO | Jan 24 | Grant / award · A | +311,798 | — | — | 311,798 |
| Milano Vincent | President and CEO | Jan 24 | Tender Offer · U | −482,281 | $50.00 | −$24.1M | 0 |
| Kirby John J. | V.P., Chief Accounting Officer | Jan 24 | Disposition to Issuer · D | −1,980 | — | — | 0 |
| Kirby John J. | V.P., Chief Accounting Officer | Jan 24 | Grant / award · A | +1,980 | — | — | 1,980 |
| Kirby John J. | V.P., Chief Accounting Officer | Jan 24 | Tender Offer · U | −60 | $50.00 | −$3K | 0 |
| McHugh Julie | Director | Jan 24 | Tender Offer · U | −8,666 | $50.00 | −$433K | 0 |
| Broom Colin Md | VP & Chief Scientific Officer | Jan 24 | Disposition to Issuer · D | −48,878 | — | — | 0 |
| Broom Colin Md | VP & Chief Scientific Officer | Jan 24 | Grant / award · A | +48,878 | — | — | 48,878 |
| Broom Colin Md | VP & Chief Scientific Officer | Jan 24 | Tender Offer · U | −154,058 | $50.00 | −$7.7M | 0 |
| Doyle Thomas F | VP Strategic Initiatives | Jan 24 | Disposition to Issuer · D | −48,878 | — | — | 0 |
| Doyle Thomas F | VP Strategic Initiatives | Jan 24 | Grant / award · A | +48,878 | — | — | 48,878 |
| Doyle Thomas F | VP Strategic Initiatives | Jan 24 | Tender Offer · U | −112,089 | $50.00 | −$5.6M | 0 |
| Fletcher Robert C. | V.P., Business Development | Jan 24 | Disposition to Issuer · D | −48,878 | — | — | 0 |
| Fletcher Robert C. | V.P., Business Development | Jan 24 | Grant / award · A | +48,878 | — | — | 48,878 |
| Fletcher Robert C. | V.P., Business Development | Jan 24 | Tender Offer · U | −37,227 | $50.00 | −$1.86M | 0 |
| Pietrusko Robert | VP, Regulatory & Quality | Jan 24 | Disposition to Issuer · D | −48,878 | — | — | 0 |
| Pietrusko Robert | VP, Regulatory & Quality | Jan 24 | Grant / award · A | +48,878 | — | — | 48,878 |
| Pietrusko Robert | VP, Regulatory & Quality | Jan 24 | Tender Offer · U | −70,877 | $50.00 | −$3.54M | 0 |
| Rowland Charles A Jr | VP, Chief Financial Officer | Jan 24 | Disposition to Issuer · D | −48,878 | — | — | 0 |
Loading...
